Specialty Pharmacy

Recent case reports indicate possible anti-lymphoma efficacy of direct-acting antivirals in patients with both lymphoma and hepatitis C.

Anemia caused by chemotherapy for lymphoid malignancies improved in patients with non-Hodgkin's lymphoma and multiple myeloma.

Warnings about the risk of ketoacidosis and serious urinary tract infections have been added to the labels of SGLT2 inhibitors.

Potentially game changing drug may alter diabetes disease course.

David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.

Recent case reports indicate possible anti-lymphoma efficacy of direct-acting antivirals in patients with both lymphoma and hepatitis C.

Researchers perform deeper analysis of recombinant factor VIII Fc fusion protein.

Epoetin alfa biosimilar shows promise in early study.

Pollutants may accelerate fibrosis, metabolic disease, and liver cancer.

Top recent news in cancer drug development.

NS3 enzyme interacts with RNA and helps the pathogen replication process.

Chemosensitivity, treatment variations, and socioeconomic factors may be a significant factor.

Excess production of tumor necrosis factor causes both RA and the onset of heart valve disease.

Depression and smoking status may be valuable targets for interventions from care providers.

Engineered antibody treatment imitates functioning factor VIII to make blood clot properly.

Catch up with any news you missed this week on Specialty Pharmacy Times.

Psychosis and hepatic fibrosis associated with earlier mortality.

Processed and red meat products like bacon and salami previously deemed carcinogenic to humans.

Legislators focus on the pricing of sofosbuvir and Harvoni.

Janssen is seeking FDA approval for ustekinumab as a Crohn's disease treatment.

A measure to delay the unpopular "Cadillac tax," part of President Obama's health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.

The World Health Organization indicates that 35 million individuals have HIV worldwide, and 4 to 5 million HIV-infected patients are co-infected with hepatitis C virus.

FDA decision expected in second half of 2016.

Study finds potential link between HCV treatment and drug-induced hepatotoxicity.

Balanced approach needed to better discriminate between high and low disease activity.

Micronutrient deficiencies in patients with HIV causes high prevalence of anemia and inflammation.

Targets for savings needed to cover retirees' health care expenses are rising.

Researchers confirm antidepressants do not cause recurrence in breast cancer patients treated with tamoxifen.